← All trials
NCT06536413
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 29, 2024
- Primary completion
- Jul 31, 2029
- Completion date
- Jul 31, 2030
- First posted
- Aug 5, 2024
- Last posted
- Nov 26, 2024
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The University of Texas, DallasLead sponsor
- The University of Texas, DallasSponsor investigator
- State of TexasCollaborator
- Methodist Cancer Center, Houston, TexasOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.